Aureus Sciences - A Life Science Knowledge Management Solutions Provider
Aureus Sciences is a privately held company incorporated in Paris in 2000 and funded mainly by major French institutional shareholders: CDC Entreprises, OTC Asset Management and AXA Private Equity.
Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases.
Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researchers involved in the drug discovery and development process.The company's range of products includes therapeutic target knowledgebases, ADME based databases and software applications:
- AurSCOPE Kinases, GPCR, Ion Channels, Proteases and Nuclear Receptors
- AurSCOPE ADME
- AurQUEST, DDI Predict, AurPROFILER, and AurPASS
-
AXA Private Equity
With $25 billion of assets managed or advised, AXA Private Equity, an AXA Investment Managers company, is a diversified private equity firm with an international reach covering eight offices in Paris, Frankfurt, London, New York, Singapore, Milan, Zurich and Vienna.
- Bioam fund: Bioam is a venture capital fund dedicated to early-stage financing of biotech companies.
FCJE fund: FCJE is a Co-investor in capital funds, and in new technological start-ups in follow-on rounds of financing.
-
OTC Asset Management invests in private companies who have a potential
for high growth and prudent risk/reward profiles.
Aureus' customers include large as well as mid-size pharmaceutical and biotech groups in Europe and North America.
The company is headquartered in Paris (France) and employs approximately 25 people, most of which are highly trained scientists in biology, pharmacology and medicinal chemistry.
Management Team
Jason Theodosiou, PhD, MBA, Chief Executive Officer – CEO
Jason Theodosiou joined Aureus in mid 2006. Jason brings extensive experience in the Life Science Informatics business. He has held various senior management positions at MDL Information Systems, SciQuest, LION bioscience AG and Elsevier MDL. Jason holds a BSc/MSc and PhD in Organic Chemistry from the University of Aix-Marseilles and an Executive MBA from the ESCP Business School of Paris
Laurence Riot-Lamotte Chief Finance Officer – CFO
Ms. Riot-Lamotte joined Aureus in 2004. After a first experience in financial audit at Deloitte & Touche, she has held various management positions at Thomson headquarters in controlling, audit and business planning, then at Deutsche Telekom France as manager business development. She holds a BBA from the CESEM of Reims (French/German cycle), a diploma of accounting and finance studies and a master in new media.
Olivier Barberan, PhD Head of Product Development
Jean-Jacques Descombes, PhD Head of IT
Christelle Morlière, PhD Head of Knowledge Management
Grégory Taounhaer Head of Marketing
Stéphane Denépoux Business Developer
Our Investors
